Profit
6 years
6 profitable years in a row. Profit 2023: €27,935.
DE ROTONDE APOTHEEK
Lifetime
18 annual accounts with figures on one time axis, 40 filings since 1984peak €166,797 (2020)
€19,270▲ 3.1%
lowest -€30,223 (2009)
€27,935▲ 0.7%
peak €441,380 (2023)
€441,380unchanged
€68,987▲ 17.6%
peak 2.4 FTE (2008)
0 FTE
Board7 names since 2020
2 directorsSTRYBOL PHARMA and 1 other
Documentsfilings and deeds
19-08-202419 days late
2023abbreviated format
Debts from €58,675 to €68,987Investments €10,433Cash from €9,985 to €2,066
Key points
from the 2023 annual accounts, the last ones filedInvestments
€10,898 13.0 × depreciation
Green is investment, beige is depreciation. Land and buildings stand 49.3% higher than in 2022.
Filings
40 annual accounts since 1984
The 2023 accounts came 19 days late. The other nine of the last ten were filed on time.
No score
Board and ownership
SI
STRYBOL Iben Ebert Raven
Director
SI
STRYBOL Ine Els Trui
Director
SK
STRYBOL Kaat Caroline Martine
Director
SW
STRYBOL Wout Jeroen Marc
Director
Recent changes
Listed in the Peppol Directory
Merger: absorbed by Strybol Invest (formerly STRYBOL PHARMA BV)
Changes of role: STRYBOL Geert Gabriel Rosina (statutory director) and DOBBELAERE Marie Anne Camilla Rita (statutory director) · Resignation: STRYBOL PHARMA BV (director) · Permanent representative: STRYBOL Geert Gabriel Rosina · Gazette deed
Merger proposal: to be absorbed by STRYBOL PHARMA
Gazette deed
Company renamed from Strybol Geert Apotheek to De Rotonde Apotheek
Resignations: DOBBELAERE Marie Anne Camilia Rita (director) and STRYBOL PHARMA (director) · Permanent representative: STRYBOL Geert Gabriel Rosina · Appointment: STRYBOL PHARMA (director) · Gazette deed
Official details
Source: KBO- Status
- Absorbed by STRYBOL PHARMAmerger by absorption, July 2024
- Activity
- “De lease, verhuur, sale and leaseback van intellectuele eigendom en vergelijkbare producten en alle…” (deed in Dutch)From the articles, 2 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Reachable since 30-01-2025
Insights on DE ROTONDE APOTHEEK
Absorbed by STRYBOL PHARMA in July 2024. The last annual accounts are for financial year 2023.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DE ROTONDE APOTHEEK
- What is the company number of DE ROTONDE APOTHEEK?
- The company number of DE ROTONDE APOTHEEK is 0424.672.037. The VAT number is the same number with BE in front: BE 0424.672.037.
- What is the legal form of DE ROTONDE APOTHEEK?
- Legal form of DE ROTONDE APOTHEEK: NV.
- Is DE ROTONDE APOTHEEK still active?
- No. DE ROTONDE APOTHEEK is inactive in the KBO register.Company details
- What is the turnover of DE ROTONDE APOTHEEK?
- The turnover in financial year 2023 is ≈ €130,000. This figure is estimated from the gross margin of €19,270 and 2,720 comparable companies of the same size. It probably lies between €54,000 and €330,000. It is a rough estimate.Financials
- Is DE ROTONDE APOTHEEK profitable?
- In financial year 2023, DE ROTONDE APOTHEEK made a profit of €27,935.
- Where can I find the annual accounts of DE ROTONDE APOTHEEK?
- DE ROTONDE APOTHEEK filed 40 annual accounts with the National Bank of Belgium, the latest for financial year 2023.